Suchergebnisse - (Person:"Lu, Qiong")

PubPharm (6)

1

Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants

enthalten in: Journal of medical virology | 2024

von Liang, Z. | Tong, J. | Sun, Z. | +11

2

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

3

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

enthalten in: Cell | 2021

von Li, Q. | Nie, J. | Wu, J. | +24

CommentIn: Signal Transduct Target Ther. 2021 Jul 27;6(1):284. - PMID 34315847

4

Comparative effectiveness of Lopinavir/Ritonavir-based regimens in COVID-19

enthalten in: Clinical and experimental pharmacology & physiology | 2021

von Qu, J. | Li, G. | Wang, J. | +6

5

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

enthalten in: Emerging microbes & infections | 2020

von Nie, J. | Li, Q. | Wu, J. | +15

6

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

enthalten in: Cell | 2020

von Li, Q. | Wu, J. | Nie, J. | +17

CommentIn: Signal Transduct Target Ther. 2020 Sep 3;5(1):185. - PMID 32883949

1
[1]